2022 report on the world markets for orthopedic biomaterials: focus on ceramics and bioactive glasses; Calcium Phosphate Cements; polymers; Metal; Composites – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Orthopedic Biomaterials Market Report 2022” report has been added to from ResearchAndMarkets.com offer.

The global orthopedic biomaterials market is expected to grow from $15.34 billion in 2021 to $16.90 billion in 2022 at a compound annual growth rate (CAGR) of 10.2%. The market is expected to reach $25.90 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%.

The major players in the orthopedic biomaterials market are Zimmer Biomet Holdings Inc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Globus Medical Inc., CAM Bioceramics BV, Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Evonik Industries AG, and Koninklijke DSM NV (DSM Biomedical BV).

The orthopedic biomaterials market includes revenue generated by establishments from the manufacture and sale of orthopedic biomaterials. Orthopedic biomaterials are materials intended for insertion into the human body as components of devices designed to perform certain biological functions by replacing or repairing various tissues, such as bones, cartilage, ligaments, tendons and others.

The orthopedic biomaterials market covered in this report is segmented by material type into bioactive ceramics and glasses, calcium phosphate cement, polymers, metals and composites. Polymers are used as orthopedic biomaterials intended to be inserted into the human body as constituents. The various applications are orthopedic implants, joint replacement/reconstruction, bioresorbable tissue fixation, orthobiology and viscosupplementation. These are used by various end users such as hospitals, clinics and others.

Rising incidence of musculoskeletal disorders is expected to drive the orthopedic biomaterials market. According to the report of the World Health Organization (WHO), musculoskeletal disorders are the main contributor to disability worldwide. Approximately 20-33% of the population suffers from a musculoskeletal disability.

The Sustainable Development Goals (SDGs) and the Decade of Healthy Aging 2020-2030 have called for increased global attention and action on musculoskeletal health. Biomaterials are used to treat these disorders. Hence, the incidence of musculoskeletal disorders is expected to drive the orthopedic biomaterials market.

The high cost of conducting clinical trials is expected to hamper the growth of the biomaterials market. Orthopedic biomaterials are implanted directly into the body. Therefore, it is important to prove the safety and biocompatibility of these materials. However, the high cost of conducting clinical trials is a major obstacle.

Clinical studies are expensive and time-consuming due to the number of tests required and the duration of each test. The investment in resources, time and funding increases in successive stages. Additional costs are associated with the outcome of trials at different phases.

For example, the cost of a failed phase 3 trial is not just the cost associated with the trial itself, but the cost of all previous trials plus the cost of time wasted researching an alternative. potentially viable or to repeat the steps. Hence, the high cost of conducting clinical trials is expected to impact the orthopedic biomaterials market.

3D printing of orthopedic implants is one of the recent developments in the orthopedic biomaterials market. 3D printing technology is used to produce a wide range of medical equipment, such as those with complex structures or features to fit a patient’s particular anatomy. 3D printing of orthopedic implants allows for the design of more natural anatomical shapes, as well as the design of porous bone replacement scaffolds that can be easily incorporated into the implant design.

This allows natural bone regeneration to generate greater implant reliability. 3D printing of orthopedic implants is a trend in the orthopedic biomaterials market that is attracting many players. For example, Evonik, a chemical company based in Germany, has invested in Meditool, a 3D printed implant start-up based in China that produces models and implants using polyether ketone (PEEK) polymer supplied by Evonik.

In November 2019, Stryker, an American Fortune 500 medical device company, entered into a definitive agreement to acquire Wright Medical for $5.4 billion. This acquisition would support and strengthen Stryker’s orthopedic segment and also provide greater exposure to Wright Medical’s extremities and biologics technologies. Wright Medical is a Dutch medical device company specializing in upper and lower limb technologies and biologics.

The countries covered in the Orthopedic Biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, United Kingdom and the United States.

Main topics covered:

1. Summary

2. Characteristics of Orthopedic Biomaterials Market

3. Orthopedic Biomaterials Market Trends and Strategies

4. Impact of COVID-19 on orthopedic biomaterials

5. Orthopedic Biomaterials Market Size and Growth

5.1. Global Historical Orthopedic Biomaterials Market, 2016-2021, USD Billion

5.1.1. Market Drivers

5.1.2. Market Constraints

5.2. Global Orthopedic Biomaterials Market Forecast, 2021-2026F, 2031F, Billion USD

5.2.1. Market Drivers

5.2.2. Market Constraints

6. Orthopedic Biomaterials Market Segmentation

6.1. Global orthopedic biomaterials market, segmentation by material type, history and forecast, 2016-2021, 2021-2026F, 2031F, billion dollars

  • Bioactive Ceramics & Glasses

  • Calcium phosphate cements

  • Polymers

  • Metal

  • Composite materials

6.2. Global orthopedic biomaterials market, segmentation by application, history and forecast, 2016-2021, 2021-2026F, 2031F, billions of dollars

  • Orthopedic implants

  • Joint replacement/reconstruction

  • Bio-absorbable tissue fixation

  • Orthobiologics

  • Viscosupplementation

6.3. Global orthopedic biomaterials market, segmentation by end user, history and forecast, 2016-2021, 2021-2026F, 2031F, billion dollars

  • Hospitals

  • Clinics

  • Other end users

7. Regional and Country Analysis of Orthopedic Biomaterials Market

7.1. Global Orthopedic Biomaterials Market, Split by Region, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

7.2. Global Orthopedic Biomaterials Market, Split by Country, Historical & Forecast, 2016-2021, 2021-2026F, 2031F, USD Billion

Companies cited

  • Zimmer Biomet Holdings Inc.

  • Stryker Company

  • Victrex-PLCs. (Invibio Ltd.)

  • Globus Medical Inc.

  • CAM Bioceramics BV

  • Heraeus Holding GmbH

  • Exactech Inc.

  • Collagen Matrix Inc.

  • Evonik Industries SA

  • Koninklijke DSM NV (DSM Biomedical BV)

  • DSM Biomedical

  • DePuy Synthes Inc.

For more information on this report, visit https://www.researchandmarkets.com/r/4y9pii

Comments are closed.